Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:36 AM
Ignite Modification Date:
2025-12-25 @ 4:36 AM
NCT ID:
NCT07195318
Eligibility Criteria:
Inclusion Criteria:
* Middle-aged or older adult (≥50 years),
* Able to cooperate cognitively,
* Able to read and understand Danish,
Exclusion Criteria:
* Inability or unwillingness to take oral supplements,
* Chronic or recent (within 30 days) use of other anti-aging supplements,
* Chronic or recent (within 30 days) treatment with medications having anti-aging effects (e.g., metformin, rapamycin, semaglutide),
* Chronic or recent (within 30 days) treatment with anti-inflammatory medications,
* Chronic or recent (within 30 days) treatment with the medications that can interact negatively with fisetin,
* Recent (within 14 days) vaccination,
* Treatment with another investigational drug or other intervention within 1 year,
* Active cancer or current cancer treatment,
* Unstable or uncontrolled major disorders, e.g., cardiovascular, renal, endocrine, immunological, hepatic disorder, or cancer, requiring regular monitoring at the hospital
* Planned medical and surgical procedures during the study period,
* Known hypersensitivity or allergy to fisetin or excipients in the placebo capsules,
* Presence of any condition that the investigator believes would put the participant at risk or would preclude the participant from successfully completing all aspects of the study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT07195318
Study Brief:
Protocol Section:
NCT07195318